Netherlands-based pharmaceutical company Mylan has announced plans to launch its first generic EpiPen. But at a cost of $300—which is half of the branded product’s list price—it’s still a heap of money for this critically important medicine.
Source: Gizmodo – Mylan’s New Generic EpiPen is Still Too Godamned Expensive